The Baltimore plant that recently had to scrap up to 15 million ruined doses had flouted rules and downplayed errors, according to internal audits, ex-employees and clients. Other doses had to be scrapped last year.The Baltimore plant that recently had to scrap up to 15 million ruined doses had flouted rules and downplayed errors, according to internal audits, ex-employees and clients. Other doses had to be scrapped last year.Vaccination and Immunization, Coronavirus (2019-nCoV), Factories and Manufacturing, Emergent BioSolutions Inc, Government Contracts and Procurement, Consumer Protection, Prices (Fares, Fees and Rates), Johnson & Johnson, AstraZeneca PLCRead More
